Feasibility of Online HIV Prevention Research for People Who Inject Drugs

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will recruit 500 people who inject drugs via social media to test the feasibility of online assessments and at-home HIV testing. Participants complete baseline online questionnaires, receive at-home HIV testing kits by mail, and mail results to a central lab. The study tracks whether online data collection is completed and whether participants correctly self-administer and return HIV tests. No additional supplies are mailed beyond the testing kits. The aim is to see if internet-based methods can support HIV prevention research in this population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 18 years or older
* US residency
* English or Spanish fluency
* injection drug use (self-report, past 30 days)
* basic reading comprehension

Exclusion Criteria:

* HIV status known to be positive

Where it's running

• Montefiore Medical Center
  The Bronx, New York, United States Recruiting

Study contacts

• Principal investigator: Aaron Fox — Montefiore Medical Center/Albert Einstein College of Medicine
• Study coordinator: Guillermo Sanchez-Fat, MD
• Email: guillermo.sanchezfat@einsteinmed.edu
• Phone: 347-514-1513

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Pharmacist-guided PEP/PrEP Access Using PEPPI Software

  This trial tests whether the PEPPI software helps pharmacists provide PEP/PrEP and helps patients access these HIV prevention options.

  Recruiting Empowerx INC · Del Mar, California · NCT07683117

• Host-led harm reduction for men who have sex with men who engage in chemsex in Bangkok

  This project will try a host-led harm reduction approach to reduce substance-related, sexual, mental health, and legal harms among men who have sex with men who engage in chemsex in Bangkok.

  Recruiting Institute of HIV Research and Innovation Foundation, Thailand · Pathum Wan, Bangkok · NCT07512869

• Transgender-tailored harm reduction and PrEP service for people who engage in chemsex in Bangkok

  This project will try a comprehensive harm-reduction service tailored for transgender and non-binary adults in Bangkok who engage in chemsex or substance use to increase PrEP use, reduce HIV/STIs, and address mental health and socio-legal needs.

  Recruiting Institute of HIV Research and Innovation Foundation, Thailand · Pathum Wan, Bangkok · NCT07512856

• See if PrEP Choice helps young people start and stick with HIV prevention methods

  This trial tests whether the PrEP Choice package helps 13-24 year-olds in the U.S. begin and continue using PrEP or DoxyPEP for HIV prevention.

  Recruiting at 6 sites Westat · San Francisco, California and 5 other locations · NCT07510048

• Adding sexual-pleasure conversations to harm reduction services for MSM and transgender people who do chemsex in Thailand

  This project will try using a 'Pleasuremeter' to guide sexual-pleasure conversations in harm reduction services for MSM and transgender people who engage in chemsex or substance use in Thailand to see if it improves sexual health, substance use, and related outcomes.

  Recruiting Institute of HIV Research and Innovation Foundation, Thailand · Pathum Wan, Bangkok · NCT07509853

• Mobile interventions to reduce HIV stigma and improve PrEP use for transgender women in Bangkok

  This project will test two mobile app-based programs to reduce HIV-related stigma and help HIV-negative transgender women aged 18–29 in Bangkok start and stick with PrEP.

  Recruiting at 3 sites Institute of HIV Research and Innovation Foundation, Thailand · Bangkok, Bangkapi and 2 other locations · NCT07509827

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.